Renal Insufficiency Articles & Analysis
3 news found
Bristol-Myers Squibb K.K. today announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy, for the treatment of adult patients with relapsed or refractory (R/R) multiple myeloma, who have received at least three prior therapies, including an ...
We report the words by Sebastiano Zannoli, founder and CEO, during the award ceremony: Angiodroid is the innovative SME that invented the first and only automatic carbon dioxide injector as a contrast medium in peripheral angiography, avoiding the complications related to the use of iodinated contrast medium in patients with renal insufficiency. Angiodroid ...
Moreover, a significant proportion also suffered from comorbidities such as diabetes (68%), hypertension (88%) and renal insufficiency (34%), “although end-stage renal disease was an exclusion characteristic,” emphasised Clair. ...